Clinical Trial Update: A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis

View source ↗

Summary

A head-to-head clinical trial is planned to compare ustekinumab with infliximab for ulcerative colitis, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Remicade (infliximab)
• Stelara (ustekinumab)

Snippet

Sponsor: Helwan University | Conditions: Ulcerative Colitis (UC) | Status: NOT_YET_RECRUITING